News

The Beneficial study, which was a Phase II double-blind, placebo-controlled, randomized trial of alagebrium in patients with chronic systolic heart failure; the Break study, which was a Phase

Under the terms of the merger transaction, Nuvelo issued approximately 4.87 million new shares of common stock to shareholders of pre-merger Arca. As a result, former Arca pre-merger

According to the company, the Taxus Liberte is the only second-generation drug-eluting stent approved for use in Japan. Design improvements over the company’s first-generation Taxus Express2 stent include

Cannasat has received a no objection letter from Health Canada to conduct this clinical study for this product that is designed to help manage neuropathic pain and other

Progression-free survival (PFS) was a prospectively defined secondary endpoint in the study. The Extend clinical trial is a Phase III single-agent trial of pixantrone for patients with relapsed,

This change in leadership is part of the restructuring process initiated by the company under the guidance of the board of directors to better prepare the company for

A patented, broad-spectrum liquid chemical warfare (CW) agent decontaminant, RSDL neutralizes or removes CW agents and T2 toxin from skin on contact, leaving a non-toxic residue that can

The Phase II trial, being conducted in the UK, is a multi-center, randomized, double-blind, placebo-controlled, dose response, factorial 12-arm parallel group study evaluating 120 patients equally randomized to

If successful, a broad-spectrum nanoviricide could be employed as an important Medical CounterMeasure against bio-terrorism and emerging infectious diseases such as Ebola or Marburg, and dengue. The company